 |
Cyclosporine |
|---|---|
| Trade Name | Pluminiq |
| Orphan Indication | Acute rejection in patients requiring allogenic lung transplants |
| USA Market Approval | USA |
| USA Designation Date | 2003-11-25 00:00:00 |
| Sponsor | APT Pharmaceuticals, Inc.;700 Airport Blvd., Suite 350;Burlingame, California, 94010 |
